missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. ABCC11 Antibody (ABCC11/2438), Novus Biologicals™
  7. 18662464

ABCC11 Antibody (ABCC11/2438), Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-23902-20ug

 View more versions of this product

Product Code. 18662464

  • 245.00 € / 20µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

ABCC11 Monoclonal antibody specifically detects ABCC11 in Human samples. It is validated for Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

ABCC11
Monoclonal
0.2 mg/mL
Immunohistochemistry-Paraffin : 1-2 μg/mL
ATP-binding cassette protein C11, ATP-binding cassette transporter MRP8, ATP-binding cassette transporter sub-family C member 11, ATP-binding cassette, sub-family C (CFTR/MRP), member 11, EWWD, MRP8ATP-binding cassette sub-family C member 11, Multidrug resistance-associated protein 8, multi-resistance protein 8, WW
Recombinant fragment (around aa400-600) of human ABCC11 protein (exact sequence is proprietary)
20 μg
Primary
Human
Purified
Immunohistochemistry (Paraffin)
ABCC11/2438
Unconjugated
10 mM PBS with 0.05% BSA
Mouse
Protein A or G purified
RUO
85320
Store at 4°C.
IgG2b κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.